Neurocrine Biosciences, Inc. (NBIX)

127.23 -1.40 (-1.09%) USD  |  NASDAQ  |  Feb 23, 10:10
More

Neurocrine Biosciences Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade